The world's first large-scale artificial pancreas rollout has delivered promising results, helping people with type 1 ...

Now a new generation of devices is trying to do something the read-only wearable never could, talk back to the body.

The UK's NHS has reported encouraging results from the first large-scale rollout of artificial pancreas systems for type 1 diabetes. The data also shows the technology reached poorer and minority ...

A read-write wearable both reads your body and writes back to it by delivering an intervention.

Detailed price information for Beta Bionics Inc (BBNX-Q) from The Globe and Mail including charting and trades.

Spread the love“`html In the realm of diabetes management, knowledge is power. One of the most essential tools in this journey is the glucose meter. Understanding how to use a glucose meter ...

Spread the love“`html Keeping an eye on blood sugar levels is crucial, especially for those living with diabetes or ...

An engineered stem cell therapy reversed new-onset Type 1 diabetes in mice by shifting the immune system away from attacking ...

The world's first artificial pancreas rollout improved blood sugar control, reduced diabetes burden, and expanded equitable ...

At the American Diabetes Association annual meeting, results from the ACHIEVE-5 trial showed that adding oral orforglipron ...

In The Lancet Diabetes & Endocrinology, Jing Luo and colleagues present the HumAn-1 trial, an important contribution to the literature on type 1 diabetes in low-income and middle-income countries ...

Once rapidly fatal, neglected, and orphan diseases without approved therapeutic options, systemic amyloidoses are now highly ...